跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Maclitax - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Maclitax
Approved
STANDARD
Maclitax
Cisen Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e762772f77ef51ee
Company
Cisen Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
e762772f77ef51ee
Drug Approval Philippines Name
Maclitax
Product Name
Maclitax
Registration Number
DRP-16002
Brand Name
Maclitax
Generic Name
Paclitaxel
Dosage Form
Solution for Injection (IV)
Dosage Strength
6 mg/mL (60 mg/10 mL)
Manufacturer
Cisen Pharmaceutical Co., Ltd.
Importer
Macropharma Corporation
Distributor
Macropharma Corporation
Company Detail Path
/organization/cisen-pharmaceutical-co-ltd-jining-shandong-china
Issuance Date
10 October 2024
Expiry Date
10 October 2029
Pharmacologic Category
Antineoplastic Agent
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e762772f77ef51ee
Type
Standard
Back to Philippines FDA Approvals